Skip to Main Content

You're in the right place to address the opioid epidemic

Register here for FREE training to treat Opioid Use Disorder (OUD)

and qualify for the waiver to prescribe buprenorphine. This course is offered in partnership with the American College of Obstetricians and Gynecologists. The curriculum for this course has been specifically designed for women’s health providers. It covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine.

This free training for providers will be conducted by the American Society of Addiction Medicine (ASAM)* and includes:

  Four hours of online training at your own pace

  Four hours of live, interactive training

And you’ll also get for FREE:

  Continuing Medical Education Available

  A copy of the ASAM National Practice Guideline

  A reference guide and other clinical resources

There are 2.1 million Americans with opioid use disorder***


Choose the one that fits your schedule:

November 8, 2019  - 8:30AM to 1:00pm CST

January 17, 2020 - 1:00pm to 5:15pm CST

+ These dates feature curriculum designed for women’s health providers in partnership with the American College of Obstetricians and Gynecologists (ACOG).

Can’t make it there on those dates? You can also participate in the live training session of your choice by streaming it on your device.


*ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

**Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.

Overview of Legislation:

Physicians

The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office-based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.